Evidence map›Paper›PMID 23943227›Full record

ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2014

Childhood central nervous system tumors at MAHAK's Pediatric Cancer Treatment and Research Center (MPCTRC), Tehran, Iran.

Azim Mehrvar, Mohammad Faranoush, Amir Abbas Hedayati Asl, Maryam Tashvighi, Mohammad Ali Fazeli, Ibrahim Qaddoumi, Narjes Mehrvar, Behdad Sobuti, Ali Jafarpour, Reza Ravan Parsa and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Management and outcomes of treating pediatric medulloblastoma: an eight years' experience in an Iranian pediatric center.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2018
    Article
  5. Comprehensive analysis of Iranian reports of pediatric central nervous system tumors.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2017
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Azim MehrvarMAHAK's Pediatric Cancer Treatment and Research Center, MAHAK Blv, Oshan Blv, Aghdasieh Ave, Tehran, 1956943512, Iran.
Mohammad Faranoush
Amir Abbas Hedayati Asl
Maryam Tashvighi
Mohammad Ali Fazeli
Ibrahim Qaddoumi
Narjes Mehrvar
Behdad Sobuti
Ali Jafarpour
Reza Ravan Parsa
Rokhsaneh Zangooei
Mardawig Alebouyeh
Parvaneh Vossough
Mahak Hospital and Rehabilitation Complex · IRIranian Legal Medicine Organization · IRIslamic Azad University Medical Branch of Tehran · IRSt. Jude Children's Research Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAs central nervous system (CNS) tumors account for second most common childhood malignancies and the first cause of mortality in children with cancer, improving treatment modalities can lead to increase the health care of patients. In this study, we examined the prevalence of childhood brain tumors in patients who referred to MAHAK's Pediatric Cancer Treatment and Research Center (MPCTRC) for treatment.

methodsA retrospective review of all children less than 15 years old with a CNS histologically proven tumor, who presented to MPCTRC from April 2007 to April 2010, was performed. Data was analyzed by SPSS version 19 with Kolmogorov-Smirnov and Chi-square tests.

resultsThere were 198 (124 boys) children eligible for the study. The majority of the tumors were infratentorial (n = 134), and the rest were supratentorial (n = 60) and spinal (n = 4) cases. The median age was 6.11 ± 3.65 years old. Medulloblastoma (n = 66), low-grade glioma (n = 52), and high-grade glioma (n = 40) were the most common tumors. The mean duration of follow-up was 21 months. At the time of this analysis, there were 105 (53 %) children alive, 82 (41.4 %) deaths, and 11 (5.6 %) lost for follow-up. The survival rate was 51.68 ± 5.22 %.

conclusionsIn contrast of high rate of death in this study, other general characteristics can serve as benchmark for improving our care for children with brain tumors in Iran.

Indexed as

AdolescentAge DistributionBenchmarkingCentral Nervous System NeoplasmsChildChild, PreschoolData Interpretation, StatisticalFemaleFollow-Up StudiesHumansInfantIranMalePrevalenceRegistriesRetrospective Studies

Identifiers

PMID23943227
OpenAlexW1963555499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.